Yasunobu Yoshinaka

A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels

Mami Ikenoya, Yasunobu Yoshinaka, Hideyuki Kobayashi et al. · Atherosclerosis · 2006 · 125 citations

Metabolic Syndrome, Lipid Disorder, Oxysterol +10

Direct Evidence for Pitavastatin Induced Chromatin Structure Change in the KLF4 Gene in Endothelial Cells

Takashi Maejima, Tsuyoshi Inoue, Yasuharu Kanki et al. · PLoS ONE · 2014 · 48 citations · Full text

Endothelial Cells, Immunology, Epigenetics +25

Mechanism of lipid‐lowering action of the dipeptidyl peptidase‐4 inhibitor, anagliptin, in low‐density lipoprotein receptor‐deficient mice

Wataru Yano, Noriyuki Inoue, Shiori Ito et al. · Journal of Diabetes Investigation · 2016 · 33 citations · Full text

A selective ACAT-1 inhibitor, K-604, stimulates collagen production in cultured smooth muscle cells and alters plaque phenotype in apolipoprotein E-knockout mice

Yasunobu Yoshinaka, Haruki Shibata, Hideyuki Kobayashi et al. · Atherosclerosis · 2010 · 32 citations

Inflammation, Collagen Production, Anti-inflammatory +15

Pitavastatin Increases ABCA1 Expression by Dual Mechanisms: SREBP2-Driven Transcriptional Activation and PPARα-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells

Takashi Maejima, Sugano Tomohiro, Hiroyuki Yamazaki et al. · Journal of Pharmacological Sciences · 2011 · 29 citations · Full text